Meridian Bioscience Inc recalls Revogene C
- Published
- 14 Jan 2026
- Units affected
- 211 units
- Agency
- FDA
- Country
- United States
The hazard
The affected lots show a decline in performance over time, which may lead to false-negative results.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
- Brand / company
- Meridian Bioscience Inc
- Codes / lots
- UDI-DI: 00840733102349; Lot Numbers: 410300U195, 410300U196, 410300U197, 410300U201
- Distribution
- US Nationwide distribution and the OUS country of Italy.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.